[PHNUTR-L] Canadian Class Action Launched Against the Manufacturer of Seroquel

[Kathrynne Holden, MS, RD]

Colleagues, the following is FYI and does not necessarily reflect my own
opinion. I have no further knowledge of the topic. If you do not wish to
receive these posts, set your email filter to filter out any messages
coming from   @nutritionucanlivewith.com    and the program will remove
anything coming from me.
---------------------------------------------------------
Canadian Class Action Launched Against the Manufacturer of Seroquel

Dow Jones - Jun. 01, 2006
http://www.therapeuticsdaily.com/news/article.cfm?contentvalue=932086&contenttype=sentryarticle&channelID=30

MONTREAL, June 1 /CNW Telbec/ - Mr. François-Luc Lavallée, a 48 year-old 
citizen of Bois-des-Fillions, Québec, is the representative Plaintiff in 
a national class action claiming more than $100,000,000 in damages and 
interest on behalf of the entire plaintiff class from the multi-national 
company AstraZeneca. Mr. Lavallee has issued a claim by way of a class 
action on behalf of all citizens, in Canada, who took the antipsychotic 
medication Seroquel(R). Seroquel(R) is prescribed for various mental 
health problems such as schizophrenia and bi-polar disorder.



Mr. Lavallée alleges having developed, among other problems, Type II 
diabetes after having used this medication and he alleges AstraZeneca 
has failed to inform the public, health authorities and patients of the 
serious health risks associated with this medication.

Seroquel(R) has been prescribed to more than 8 million people across the 
globe. This drug is a sales leader in the atypical antipsychotic 
pharmaceutical market in the United States and in Canada. The plaintiff 
class is estimated at thousands of persons. Many legal actions have been 
filed in the United States and in Canada, namely in Alberta, and British 
Columbia alleging similar claims.

Mr. Lavallée is represented by Lauzon Bélanger, a prominent class action 
firm in Canada, which works in close collaboration with McNally Cuming 
Raymaker who represents claimants from Alberta, and British Columbia, as 
well as Roy Elliott Kim O'Connor who represents class members in Ontario.

All persons interested by this class action request may consult the 
complete text of the motion on Lauzon Bélanger's Web site at 
www.lauzonbelanger.qc.ca or contact the firm's Member Services by e-mail 
to serviceauxmembres at lauzonbelanger.qc.ca or by phone at 514-287-1000 or 
1-800-287-8587.

For Ontario inquiries, please contact REKO LLP at www.reko.ca , by 
e-mail to info at reko.ca or by phone at 416-362-1989.

In Western Canada, please contact McNally Cuming Raymaker, at 
www.mcnallycuming.com, by e-mail to rfogel at mcnallycuming.com, or by 
phone at 1-800-682-2480.

/CONTACT: Anna Vetere, director, Lauzon Bélanger inc., (514) 287-1000, 
1-800-287-8587

(END) Dow Jones Newswires

June 01, 2006 09:49 ET (13:49 GMT)
-- 
Kathrynne Holden, MS, RD < fivestar at nutritionucanlivewith.com >
"Ask the Parkinson Dietitian"  http://www.parkinson.org/
"Eat well, stay well with Parkinson's disease"
"Parkinson's disease: Guidelines for Medical Nutrition Therapy"
http://www.nutritionucanlivewith.com/